Ergomed PLC (LSE:ERGO) - Share price - Overview

Stock Report

Ergomed PLC ERGO

Last Price
GBX195.00

Day Change
-0.50|-0.26%

As of 17/11/2017
16:38:30 GMT | GBX
Minimum 15 Minutes Delay.

Last Close195.50p
Day Range193.00 - 193.00
Mkt Cap83.44Mil
52-Wk Range128.20 - 225.00
Yield %0.00
ISINGB00BN7ZCY67
Volume327,894
P/E64.14
P/S1.77
P/CF-29.22

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Ergomed PLC5.98 
FTSE 100 TR GBP-1.44
 
Financials
201420152016
More ...
Income Statement
Turnover21.1630.1839.23
Operating Profit0.782.070.60
Net Profit0.581.550.48
Reported EPS2.305.201.30
Balance Sheet
Current Assets10.9213.5019.83
Non Current Assets10.7611.1934.56
Total Assets21.6824.6954.40
Current Liabilities5.767.238.59
Total Liabilities6.347.7619.79
Total Equity15.3416.9434.61
Cash Flow
Operating Cash Flow0.970.85-1.43
Net Change in Cash2.63-0.600.45
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20172.197.00130.2327.930.21--
20185.2311.7067.1416.710.25--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/10/2017PurchaseMr. Peter George165.0045,00074,250.00
03/04/2017PurchaseMr. Peter George190.00100,000190,000.00

Company Profile

Ergomed PLC is engaged in providing services to the pharmaceutical industry and develops new drugs. The Company operates in two business divisions namely Services Business and Co-Development Business.

Sector

Biotechnology

Market Position

968 of 1833 Companies

Index

FTSE AIM All Share

Outlook

(18/09/2017) "...the board remains positive on the outlook for the company"

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)17.5813.7216.17
Div Yld (E)0.004.104.26
PEG (E)0.251.221.34
ROCE18.10180.1215.99
Op Mrgn2.72-8.55-10.68
EPS Grwth70.7712.9914.76
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Peter George
Chief Financial OfficerStephen Stamp
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.